[1]
H. Yanai, H. Adachi, M. Hakoshima, and H. Katsuyama, “Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 Diabetes”, J Clin Med Res, vol. 17, no. 9, pp. 469–489, Oct. 2025, doi: 10.14740/jocmr6370.